{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:40:33Z","timestamp":1790836833666,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Intratumoral and circulating regulatory T cells (Tregs) have been shown to be critical in the pathogenesis of hepatocellular carcinoma (HCC). However there is limited knowledge on the alterations of regulatory B cells (Bregs). We here investigated perioperative dynamic alterations of peripheral circulating Tregs and Bregs in HCC patients to reveal the relationship between regulatory lymphocytes and its clinical implications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>36 patients with HCC, 6 with chronic hepatitis B infection and 10 healthy donors were enrolled for this study. Frequencies of peripheral Tregs and Bregs were measured by flow cytometry with antibodies against CD4, CD25, CD127, CD19 and IL-10 before, and after radical surgery. Then, clinical informatics of HCC patients was achieved through Digital Evaluation Score System (DESS) for the assessment of disease severity. Finally, we analysed correlations between digitalized clinical features and kinetics of circulating regulatory lymphocytes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Level of circulating CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup>CD127<jats:sup>-<\/jats:sup>Tregs in HCC patients was significantly lower than that in healthy donors and patients with chronic hepatitis B infection before surgery, but was increased after surgery. Preoperative level of CD19<jats:sup>+<\/jats:sup>IL-10<jats:sup>+<\/jats:sup>Bregs in HCC patients was also significantly lower than the other groups. However it dramatically was elevated right after surgery and remained elevated compared to controls (about 7 days after surgery,<jats:italic>P<\/jats:italic>= 0.04). Frequency of circulating Tregs was correlated with circulating leukocytes, ferritin, and clinical features suggesting tumor aggressiveness including portal vein thrombosis, hepatic vein involvement and advanced clinical stages. Frequency of circulating Bregs was associated with Hepatitis B e Antigen (HBeAg) and Hepatitis B virus (HBV) DNA copy number. In addition, DESS was significantly and positively correlated with other staging systems.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Frequencies of peripheral Tregs and Bregs in HCC patients increased after surgery. These results suggest that a postoperative combination of therapies against Tregs and Bregs may be beneficial for better outcome of HCC patients after resection.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1479-5876-10-14","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T07:25:31Z","timestamp":1327476331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma"],"prefix":"10.1186","volume":"10","author":[{"given":"Tianxiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bajin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,25]]},"reference":[{"key":"986_CR1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","volume":"127","author":"H Nishikawa","year":"2010","unstructured":"Nishikawa H, Sakaguchi S: Regulatory T cells in tumor immunity. Int J Cancer. 2010, 127: 759-767.","journal-title":"Int J Cancer"},{"key":"986_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.coi.2008.04.008","volume":"20","author":"TJ Curiel","year":"2008","unstructured":"Curiel TJ: Regulatory T cells and treatment of cancer. Curr Opin Immunol. 2008, 20: 241-246. 10.1016\/j.coi.2008.04.008.","journal-title":"Curr Opin Immunol"},{"key":"986_CR3","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","volume":"25","author":"Q Gao","year":"2007","unstructured":"Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007, 25: 2586-2593. 10.1200\/JCO.2006.09.4565.","journal-title":"J Clin Oncol"},{"key":"986_CR4","volume-title":"Med Oncol","author":"KJ Chen","year":"2011","unstructured":"Chen KJ, Zhou L, Xie HY, Ahmed TE, Feng XW, Zheng SS: Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. Med Oncol. 2011"},{"key":"986_CR5","volume-title":"Surgery","author":"WC Lee","year":"2011","unstructured":"Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC: The impact of CD4(+)CD25(+) T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery. 2011"},{"key":"986_CR6","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-04-3232","volume":"65","author":"LA Ormandy","year":"2005","unstructured":"Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F: Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 2005, 65: 2457-2464. 10.1158\/0008-5472.CAN-04-3232.","journal-title":"Cancer Res"},{"key":"986_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jhep.2006.01.036","volume":"45","author":"XH Yang","year":"2006","unstructured":"Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y: Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol. 2006, 45: 254-262. 10.1016\/j.jhep.2006.01.036.","journal-title":"J Hepatol"},{"key":"986_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrrheum.2010.140","volume":"6","author":"C Mauri","year":"2010","unstructured":"Mauri C, Blair PA: Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol. 2010, 6: 636-643. 10.1038\/nrrheum.2010.140.","journal-title":"Nat Rev Rheumatol"},{"key":"986_CR9","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1158\/0008-5472.CAN-05-3766","volume":"66","author":"S Inoue","year":"2006","unstructured":"Inoue S, Leitner WW, Golding B, Scott D: Inhibitory effects of B cells on antitumor immunity. Cancer Res. 2006, 66: 7741-7747. 10.1158\/0008-5472.CAN-05-3766.","journal-title":"Cancer Res"},{"key":"986_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.it.2007.10.004","volume":"29","author":"C Mauri","year":"2008","unstructured":"Mauri C, Ehrenstein MR: The 'short' history of regulatory B cells. Trends Immunol. 2008, 29: 34-40. 10.1016\/j.it.2007.10.004.","journal-title":"Trends Immunol"},{"key":"986_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","volume":"176","author":"A Mizoguchi","year":"2006","unstructured":"Mizoguchi A, Bhan AK: A case for regulatory B cells. J Immunol. 2006, 176: 705-710.","journal-title":"J Immunol"},{"key":"986_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2010.09.010","volume":"48","author":"G Vitale","year":"2010","unstructured":"Vitale G, Mion F, Pucillo C: Regulatory B cells: evidence, developmental origin and population diversity. Mol Immunol. 2010, 48: 1-8. 10.1016\/j.molimm.2010.09.010.","journal-title":"Mol Immunol"},{"key":"986_CR13","first-page":"3420","volume":"118","author":"T Matsushita","year":"2008","unstructured":"Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF: Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008, 118: 3420-3430.","journal-title":"J Clin Invest"},{"key":"986_CR14","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","volume":"184","author":"R Watanabe","year":"2010","unstructured":"Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, Sato S, Tedder TF, Fujimoto M: Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol. 2010, 184: 4801-4809. 10.4049\/jimmunol.0902385.","journal-title":"J Immunol"},{"key":"986_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ajpath.2010.10.022","volume":"178","author":"K Yanaba","year":"2011","unstructured":"Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S: IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol. 2011, 178: 735-743. 10.1016\/j.ajpath.2010.10.022.","journal-title":"Am J Pathol"},{"key":"986_CR16","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","volume":"71","author":"PB Olkhanud","year":"2011","unstructured":"Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP, Biragyn A: Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 T cells to T-regulatory cells. Cancer Res. 2011, 71: 3505-3515. 10.1158\/0008-5472.CAN-10-4316.","journal-title":"Cancer Res"},{"key":"986_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","volume":"1183","author":"DJ DiLillo","year":"2010","unstructured":"DiLillo DJ, Matsushita T, Tedder TF: B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010, 1183: 38-57. 10.1111\/j.1749-6632.2009.05137.x.","journal-title":"Ann N Y Acad Sci"},{"key":"986_CR18","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1073\/pnas.1100994108","volume":"108","author":"T Schioppa","year":"2011","unstructured":"Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, Nedospasov S, Mauri C, Coussens LM, Balkwill FR: B regulatory cells and the tumor-promoting actions of TNF-alpha during squamous carcinogenesis. Proc Natl Acad Sci USA. 2011, 108: 10662-10667. 10.1073\/pnas.1100994108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR19","volume-title":"J Cell Mol Med","author":"H Chen","year":"2011","unstructured":"Chen H, Song Z, Qian M, Bai C, Wang X: Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J Cell Mol Med. 2011"},{"key":"986_CR20","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM: Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med. 2004, 350: 1118-1129. 10.1056\/NEJMra031087.","journal-title":"N Engl J Med"},{"key":"986_CR21","volume-title":"Eur J Cancer","author":"YH Chun","year":"2011","unstructured":"Chun YH, Kim SU, Park JY, Kim DY, Han KH, Chon CY, Kim BK, Choi GH, Kim KS, Choi JS, Ahn SH: Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer. 2011"},{"key":"986_CR22","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.6189183","volume":"220","author":"F Barre-Sinoussi","year":"1983","unstructured":"Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983, 220: 868-871. 10.1126\/science.6189183.","journal-title":"Science"},{"key":"986_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","volume":"322","author":"M Bull","year":"2007","unstructured":"Bull M, Lee D, Stucky J, Chiu YL, Rubin A, Horton H, McElrath MJ: Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods. 2007, 322: 57-69. 10.1016\/j.jim.2007.02.003.","journal-title":"J Immunol Methods"},{"key":"986_CR24","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/cc8876","volume":"14","author":"F Hein","year":"2010","unstructured":"Hein F, Massin F, Cravoisy-Popovic A, Barraud D, Levy B, Bollaert PE, Gibot S: The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states. Crit Care. 2010, 14: R19-10.1186\/cc8876.","journal-title":"Crit Care"},{"key":"986_CR25","volume-title":"J Neuroimmunol","author":"S Knippenberg","year":"2011","unstructured":"Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J: Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission. J Neuroimmunol. 2011"},{"key":"986_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2011","unstructured":"Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD: Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011, 117: 530-541. 10.1182\/blood-2010-07-294249.","journal-title":"Blood"},{"key":"986_CR27","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1872-034X.2010.00714.x","volume":"40","author":"T Kawaoka","year":"2010","unstructured":"Kawaoka T, Aikata H, Takaki S, Hashimoto Y, Katamura Y, Hiramatsu A, Waki K, Takahashi S, Kamada K, Kitamoto M: Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems. Hepatol Res. 2010, 40: 1082-1091. 10.1111\/j.1872-034X.2010.00714.x.","journal-title":"Hepatol Res"},{"key":"986_CR28","first-page":"1181","volume":"98","author":"MF Yuen","year":"2003","unstructured":"Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL: Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol. 2003, 98: 1181-1185.","journal-title":"Am J Gastroenterol"},{"key":"986_CR29","volume-title":"Ann Surg Oncol","author":"R Santambrogio","year":"2011","unstructured":"Santambrogio R, Opocher E, Costa M, Barabino M, Zuin M, Bertolini E, De Filippi F, Bruno S: Hepatic Resection for \"BCLC Stage A\" Hepatocellular Carcinoma. The Prognostic Role of Alpha-Fetoprotein. Ann Surg Oncol. 2011"},{"key":"986_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s005350300038","volume":"38","author":"M Kudo","year":"2003","unstructured":"Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003, 38: 207-215. 10.1007\/s005350300038.","journal-title":"J Gastroenterol"},{"key":"986_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2007.07.025","volume":"47","author":"M Zabala","year":"2007","unstructured":"Zabala M, Lasarte JJ, Perret C, Sola J, Berraondo P, Alfaro M, Larrea E, Prieto J, Kramer MG: Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer. J Hepatol. 2007, 47: 807-815. 10.1016\/j.jhep.2007.07.025.","journal-title":"J Hepatol"},{"key":"986_CR32","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.4049\/jimmunol.0903143","volume":"184","author":"SA Patel","year":"2010","unstructured":"Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P: Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol. 2010, 184: 5885-5894. 10.4049\/jimmunol.0903143.","journal-title":"J Immunol"},{"key":"986_CR33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11596-008-0606-7","volume":"28","author":"B Xiong","year":"2008","unstructured":"Xiong B, Feng G, Luo S, Liang H, Qiu L, Zheng C, Liu X, Zhou G: Changes of CD4(+) CD25 (+) regulatory T cells in peripheral blood in patients with hepatocellular carcinoma before and after TACE. J Huazhong Univ Sci Technolog Med Sci. 2008, 28: 645-648. 10.1007\/s11596-008-0606-7.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"986_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00005-011-0127-0","volume":"59","author":"X Feng","year":"2011","unstructured":"Feng X, Li B, Ye H, Long D: Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma. Arch Immunol Ther Exp (Warsz). 2011, 59: 309-314. 10.1007\/s00005-011-0127-0.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"986_CR35","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St, Groth B: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006, 203: 1701-1711. 10.1084\/jem.20060772.","journal-title":"J Exp Med"},{"key":"986_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W: Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006, 6: 295-307. 10.1038\/nri1806.","journal-title":"Nat Rev Immunol"},{"key":"986_CR37","doi-asserted-by":"publisher","first-page":"e24671","DOI":"10.1371\/journal.pone.0024671","volume":"6","author":"KJ Chen","year":"2011","unstructured":"Chen KJ, Lin SZ, Zhou L, Xie HY, Zhou WH, Taki-Eldin A, Zheng SS: Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis. PLoS One. 2011, 6: e24671-10.1371\/journal.pone.0024671.","journal-title":"PLoS One"},{"key":"986_CR38","volume-title":"J Cell Mol Med","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wang W, Wang L, Wang X, Xia J: Regulatory mechanisms of interleukin 8 production induced by tumor necrosis factor-alpha in human hepatocellular carcinoma cells. J Cell Mol Med. 2011"},{"key":"986_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","volume":"16","author":"A Mizoguchi","year":"2002","unstructured":"Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK: Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002, 16: 219-230. 10.1016\/S1074-7613(02)00274-1.","journal-title":"Immunity"},{"key":"986_CR40","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.4049\/jimmunol.1001307","volume":"185","author":"T Matsushita","year":"2010","unstructured":"Matsushita T, Horikawa M, Iwata Y, Tedder TF: Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010, 185: 2240-2252. 10.4049\/jimmunol.1001307.","journal-title":"J Immunol"},{"key":"986_CR41","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","volume":"186","author":"NA Carter","year":"2011","unstructured":"Carter NA, Vasconcellos R, Rosser EC, Tulone C, Munoz-Suano A, Kamanaka M, Ehrenstein MR, Flavell RA, Mauri C: Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells. J Immunol. 2011, 186: 5569-5579. 10.4049\/jimmunol.1100284.","journal-title":"J Immunol"},{"key":"986_CR42","first-page":"960","volume":"58","author":"L Geng","year":"2011","unstructured":"Geng L, Deng J, Jiang G, Song P, Wang Z, Jiang Z, Zhang M, Zheng S: B7-H1 up-regulated expression in human hepatocellular carcinoma tissue: correlation with tumor interleukin-10 levels. Hepatogastroenterology. 2011, 58: 960-964.","journal-title":"Hepatogastroenterology"},{"key":"986_CR43","first-page":"841","volume":"36","author":"HH Zhang","year":"2010","unstructured":"Zhang HH, Mei MH, Fei R, Liao WJ, Wang XY, Qin LL, Wang JH, Wei L, Chen HS: Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro. Int J Oncol. 2010, 36: 841-848.","journal-title":"Int J Oncol"},{"key":"986_CR44","first-page":"37","volume":"Part 2","author":"DSaA Bahlo","year":"2011","unstructured":"Bahlo DSaA: B Lymphocytes in Cancer Immunology. Experimental and Applied Immunotherapy. 2011, Part 2: 37-57.","journal-title":"Experimental and Applied Immunotherapy"},{"key":"986_CR45","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos D, Jitschin R, Johansson CC, Okita R, Kiessling R, Le Blanc K: The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood. 2011, 117: 4826-4835. 10.1182\/blood-2010-12-324038.","journal-title":"Blood"},{"key":"986_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.1269","volume":"92","author":"CP Gray","year":"2001","unstructured":"Gray CP, Franco AV, Arosio P, Hersey P: Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production. Int J Cancer. 2001, 92: 843-850. 10.1002\/ijc.1269.","journal-title":"Int J Cancer"},{"key":"986_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2043-9113-1-2","volume":"1","author":"C Baumgartner","year":"2011","unstructured":"Baumgartner C, Osl M, Netzer M, Baumgartner D: Bioinformatic-driven search for metabolic biomarkers in disease. J Clin Bioinforma. 2011, 1: 2-10.1186\/2043-9113-1-2.","journal-title":"J Clin Bioinforma"},{"key":"986_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2043-9113-1-1","volume":"1","author":"X Wang","year":"2011","unstructured":"Wang X, Liotta L: Clinical bioinformatics: a new emerging science. J Clin Bioinforma. 2011, 1: 1-10.1186\/2043-9113-1-1.","journal-title":"J Clin Bioinforma"},{"key":"986_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2043-9113-1-28","volume":"1","author":"X Wang","year":"2011","unstructured":"Wang X: Role of clinical bioinformatics in the development of network-based Biomarkers. J Clin Bioinforma. 2011, 1: 28-10.1186\/2043-9113-1-28.","journal-title":"J Clin Bioinforma"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-10-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T12:16:54Z","timestamp":1713442614000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-10-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,25]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-10-14","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,25]]},"assertion":[{"value":"1 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"14"}}